Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor

Diabetologia

Volumn 40, Issue SUPPL. 2, 1997, Pages

  Ish Shalom, D ^a   Christoffersen, C T ^b   Vorwerk, P ^b   Sacerdoti Sierra, N ^a   Shymko, R M ^b   Naor, D ^a   De Meyts, P ^b  

^a HEBREW UNIVERSITY   (Israel)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

IGF I receptor; Insulin analogues; Insulin receptor; Mitogenic signalling; T cell lymphoma

Indexed keywords

INSULIN; INSULIN DERIVATIVE; INSULIN RECEPTOR;

CONFERENCE PAPER; DIABETES MELLITUS; DRUG RECEPTOR BINDING; HORMONE RECEPTOR INTERACTION; HUMAN; INSULIN METABOLISM; METABOLIC REGULATION; MITOGENESIS; PRIORITY JOURNAL;

ANIMALS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LYMPHOMA, T-CELL; MICE; MITOGENS; RECEPTOR, INSULIN; TUMOR CELLS, CULTURED;

EID: 0030851268     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051393     Document Type: Conference Paper

References (45)

1. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212
2. Moses AC, Tzuzaki S (1991) Is insulin a growth factor? In: LeRoith D (ed) Insulin-like growth factors, molecular and cellular aspects. CRC Press, Boca Raton Ann Harbor Boston London, pp 245-270
3. Soos MA, Field CE, Siddle K (1993) Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 290: 419-426
4. Sweet LJ, Morrison BD, Pessin J (1987) Isolation of functional a-b heterodimers from (he purified human placental α2-β2 heterotetrameric insulin receptor concept. Structural basis for high affinity ligand binding. J Biol Chem 262: 6939-6942
5. Beguinot F, Smith RJ, Kahn CR, Maron R, Moses AC, White MF (1988) Phosphorylation of insulin-like growth factor-I receptor by insulin receptor tyrosine kinase in intact cultured skeletal muscle cells. Biochemistry 27: 3222-3228
6. Moxham C, Jacobs S (1992) Insulin-like growth factor receptors. In: Schofield P (ed) The insulin-like growth factors. Structure and biological functions. Oxford University Press, Oxford New York Tokyo, pp 80-109
7. De Meyts P (1994) The structural basis of insulin and insulin-like growth factor-I (IGF-I) receptor binding and negative co-opcrativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37[Suppl 2]:S135-S148
8. De Meyts P, Wallach B, Christoffersen CT et al. (1994) The insulin-like growth factor-I receptor. Structure, ligand binding mechanism and signal transduclion. Horm Res 42: 152-169
9. Maggi D, Laurino C, Andraghetti G, Cordera R (1994) The overexpression of insulin receptor makes CHO cells resistant to the action of IGF-I. Role of IRS-1. Biochem Biophys Res Commun 205: 693-699
10. Wang LH, Lin B, Jong S-MJ, Dixon D, Ellis L, Roth RA, Rutter WJ (1987) Activation of the transforming potential of the human insulin receptor gene. Proc Natl Acad Sci USA 84: 5725-5729
11. Dideriksen LH, Jørgensen LN, Drejer K (1992) Carcinogenic effect on female rats after 12 months administration of the insulin analogue BlO Asp. Diabetes 41 [Suppl 1]:143A (Abstract)
12. Bornfeldt KE, Gidlöf RA, Wasteson A, Lake M, Skottner A, Arnqvist HJ (1991) Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth-promoting activities. Diabetologia 34: 307-313
13. De Meyts P, Christoffersen CT, Ursø B et al. (1993) Insulin potency as a mitogen is determined by the half-life of the insulin-receptor complex. Exp Clin Endocrinol Leipzig 101: 22-23
14. Hansen BF, Danielsen GM, Drejer K et al. (1996) Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J 315: 271-279
15. Kaaks R (1996) Nutrition, hormones, and breast cancer: Is insulin the missing link? Cancer causes and control 7: 605-625
16. Koontz JW, Iwahashi M (1981) Insulin as a potent, specific growth factor in a rat hepatoma cell line. Science 211: 947-949
17. Petersen B, Blecher M (1979) Insulin receptors and functions in normal and spontaneously transformed cloned rat hepatocytes. Exp Cell Res 120: 119-125
18. Hofmann C, Marsh JW, Miller B, Steiner DF (1980) Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness. Diabetes 29: 865-874
19. Nagarajan L, Anderson WB (1982) Insulin promotes the growth of F9 embryonal cells apparently by acting through its own receptor. Biochem Biophys Res Commun 106: 974-980
20. Freund GG, Kulas DT, Mooney RA (1993) Insulin and IGF-I increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI-8226. J lmmunol 151: 1811-1820
21. Mamounas M, Gervin D, Englesberg E (1989) The insulin receptor as a transmitter of a mitogenic signal in Chinese hamster ovary CHO-K1 cells. Proc Natl Acad Sci U.S.A. 86: 9294-9298
22. Mamounas M, Ross S, Luong CL et al. (1991) Analysis of the genes involved in the transmembrane mitogenic signal in Chinese hamster ovary cells, CHO-K1, utilizing insulin-independent mutants. Proc Natl Acad Sci USA 88: 3524-3530
23. Lammers R, Gray A, Schlessinger J, Ullrich A (1989) Differential signalling potential of insulin- and IGF-I-receptor cytoplasmic domains. EMBO J 8: 1369-1375
24. Ish-Shalom D, Tzivion G, Christoffersen CT, Ursø B, De Meyts P Naor D (1995) Mitogenic potential of insulin on lymphoma cells lacking IGF-I receptors. Ann N Y Acad Sci 766: 409-415
25. Zahalka AM, Okon E, Gosslar U, Holzmann B, Naor D (1995) Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate dependent. J Immunol 154: 5345-5355
26. Ruggiero RA, Bustuoabad OD, Bonfil RD, Meiss RP, Pasqualini CD (1985) "Concomitant immunity" in murine tumours of non-detectable immunogenicity. Brit J Cancer 51: 37-48
27. Meiss RP, Bonfil RD, Ruggiero RA, Pasqualini CD (1986) Histologie aspects of concomitant resistance induced by non-immunogenic murine tumours. J Natl Cancer Inst 76: 1163-1175
28. Pillemer G, Lugasi-Evgi H, Scharovski G, Naor D (1992) Insulin dependence of murine lymphoid T-cell leukemia. Int J Cancer 50: 80-85
29. Sharon R, Pillemer G, Ish-Shalom D et al. (1993) Insulin dependence of murine T-cell lymphoma. 2. Insulin-deficient mice and mice fed low-energy diet develop resistance to lymphoma growth. Int J Cancer 53: 843-849
30. Christoffersen CT, Bornfeldt KE, Rotella CM et al. (1994) Negative co-operativity in the insulin-like growth factor-I (IGF-I) receptor and a chimeric IGF-I/insulin receptor. Endocrinology 135: 472-475
31. De Meyts P (1976) Insulin and growth hormone receptors in human cultured lymphocytes and peripheral blood monocytes. In: Blecher M (ed) Methods in receptor research. Marcel Dekker, New York, pp 301-383
32. De Meyts P, Bianco AR, Roth J (1976) Site-site interactions among insulin receptors: characterization of the negative co-operativity. J Biol Chem 251: 1877-1888
33. De Meyts P, Van Obberghen E, Roth J, Brandenburg D, Wollmer A (1978) Mapping of the residues of the receptor binding region of insulin responsible for the negative cooperativity. Nature 273: 504-509
34. Brange J, Owens D, Kang S, Vølund A (1990) Monomeric insulins and their experimental and clinical implications. Diabetes Care 13: 923-954
35. Drejer K (1992) The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 8: 259-286
36. Flores-Riveros JR, Sibley E, Kastelic C, Lane MD (1989) Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. J Biol Chem 264: 21557-21572
37. Taylor S, Cama A, Accili D et al. (1992) Mutations in the insulin receptor gene. Endocrine Rev 13: 566-595
38. Lee PD, Rosenfeld RG, Hintz RL, Smith SD (1986) Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J Clin Endo Metab 62: 28-35
39. Braciale VL, Gavin JRI, Braciale TJ (1982) Inducible expression of insulin receptors on T lymphocyte clones. J Exp Med 156: 664-669
40. De Meyts P, Christoffersen CT, Tornqvist H, Seedorf K (1996) Insulin receptors and insulin action. Curr Opinion Endo Diab 3: 369-377
41. De Meyts P, Christoffersen CT, Ursø B et al. (1995) Role of the time factor in signalling specificity. Application to mitogenic and metabolic signalling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism 44[Suppl4]:1-11
42. De Meyts P, Ursø B, Christoffersen CT, Shymko RM (1995) Mechanism of insulin and IGF-I receptor activation and signal transduction specificity. Receptor dimer crosslinking, bell-shaped curves, and sustained versus transient signalling. Ann New York Acad Sci 766: 388-401
43. Adair GS (1925) The hemoglobin system. VI. The oxygen dissociation curve of hemoglobin. J Biol Chem 63: 529-545
44. Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts CT Jr, LeRoith D (1989) Developmental regulation of the rat insulin-like growth factor-I receptor gene. Proc Natl Acad Sci 86: 7451-7455
45. Rutter WJ, Morgan D, Ebina Y, Wang LH, Roth R, Ellis L (1988) Membrane linked insulin receptor tyrosine kinase stimulates the insulin specific response. In: Goren HJ, Hollenberg MD, Roncari DAK (eds) Insulin action and diabetes. Raven Press. New York, pp 1-12